LaFleur launches its high-quality CBD flowers
LaFleur, one of France's pioneering medical cannabis companies, recently announced the launch of its first CBD flowers, marking an important milestone in the industry.
While current French regulations prohibit the production of THC-rich cannabis flowers, LaFleur has decided to produce CBD flowers from the Enectaliana variety on its state-of-the-art cultivation site.
High-quality indoor cultivation
The LaFleur CBD flowers are grown indoors in a meticulously controlled environment, guaranteeing consistent quality and reproducibility. This indoor cultivation is enhanced by the use of hortimind®AI technology, which optimizes fertilizer, energy and water consumption. By relying on this cutting-edge technology developed in-house, LaFleur not only guarantees a high level of product quality, but also adheres to sustainable, environmentally-friendly practices.
One of the unique aspects of LaFleur's product is the decision to offer crushed CBD flowers. This approach takes into account the natural variability of cannabinoid and terpene concentrations in different parts of the plant. By crushing the flowers, LaFleur guarantees a homogeneous product, ensuring that each package offers a consistent and reproducible experience to the user.
The Enectaliana variety used by LaFleur is listed in the European Hemp Catalogue and meets the regulatory requirement of a THC content of less than 0.3%. The flowers are grown hydroponically, a method that considerably reduces the use of water and fertilizers compared with traditional field cultivation. This technique also minimizes the risk of heavy metal contamination, as the plants are grown on controlled inert substrates.

LaFleur's crushed CBD flowers
Commitment to sustainable, pesticide-free practices
LaFleur's commitment to quality extends to its cultivation methods. CBD flowers are grown without the use of pesticides, thanks to a system of integrated biological control. This system uses predatory insects to fight pests naturally, ensuring that plants thrive in a healthy environment without the need for chemical intervention.
Each batch of CBD flowers undergoes in-depth analysis to determine cannabinoid and terpene content. This process is carried out using methods developed and validated in-house in accordance with pharmaceutical standards, guaranteeing the highest level of accuracy and reliability. In addition, LaFleur takes significant steps to control the risk of microbiological contamination by maintaining rigorous hygiene and cleanliness protocols in its cultivation facilities.
LaFleur's production process complies with Good Harvesting and Agricultural Practices (GHAAP), guaranteeing traceability and quality throughout the cultivation cycle. Every action and every product used in the cultivation process is meticulously recorded. The company is also ISO 9001 certified, the benchmark for quality system certification.
Product details
LaFleur CBD flowers are available in ready-to-use 5-gram resealable bags. These flowers have a natural CBD content of 7% and a THC content of less than 0.3%. Available at terpenes, The 2 main terpenes are myrcene, known for its sedative properties, and beta-caryophyllene, which is more anti-inflammatory. The flowers are 100 % natural and embody the purity and quality that LaFleur strives for.
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login